Techno Drugs (DHA:TECHNODRUG) Long-Term Debt: BDT2,396 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:TECHNODRUG Techno Drugs Ltd DHA:TECHNODRUG
37 GF Score
Price BDT42.70
! 5 Warning Signs
View Full Analysis

What is Techno Drugs Long-Term Debt?

Techno Drugs DHA:TECHNODRUG -1.39% 37 Long-Term Debt is BDT2,396 Mil as of Mar. 2026. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 5 warning signs investors should review.

Techno Drugs's Long-Term Debt for the quarter that ended in Mar. 2026 was BDT2,396 Mil.

Techno Drugs's quarterly Long-Term Debt increased from Sep. 2025 (BDT1,715 Mil) to Dec. 2025 (BDT2,406 Mil) but then declined from Dec. 2025 (BDT2,406 Mil) to Mar. 2026 (BDT2,396 Mil).

Techno Drugs's annual Long-Term Debt increased from . 20 (BDT0 Mil) to Jun. 2024 (BDT1,212 Mil) and increased from Jun. 2024 (BDT1,212 Mil) to Jun. 2025 (BDT1,560 Mil).

Techno Drugs  (DHA:TECHNODRUG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Techno Drugs Long-Term Debt Related Terms

Techno Drugs Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Techno Drugs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Drugs Long-Term Debt Chart

Techno Drugs Annual Data
Trend Jun24 Jun25
Long-Term Debt
1,212.09 1,559.70

Techno Drugs Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,531.54 1,559.70 1,714.93 2,406.10 2,395.64
DHA:TECHNODRUG
37GF Score
Techno Drugs Ltd DHA:TECHNODRUG
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of BDT2,396 Mil mean?
Techno Drugs (DHA:TECHNODRUG) has a Long-Term Debt of BDT2,396 Mil as of Mar. 2026.
Is Techno Drugs' Long-Term Debt too high?
Techno Drugs' current Long-Term Debt is BDT2,396 Mil. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' Long-Term Debt compare to ZTS and UTHR?
Techno Drugs' Long-Term Debt of BDT2,396 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Techno Drugs's current Long-Term Debt is BDT2,396 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current Long-Term Debt of BDT2,396 Mil. The current Long-Term Debt is BDT2,396 Mil. Techno Drugs' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current Long-Term Debt is BDT2,396 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Techno Drugs Business Description

Address 31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score

Get the complete analysis for DHA:TECHNODRUG

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT42.70
Price